Select Equity Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147M | Sell |
299,500
-15,532
| -5% | -$8.43M | 0.75% | 38 |
|
|
2025
Q4 | $183M | Buy |
315,032
+153,553
| +95% | +$86.8M | 0.79% | 34 |
|
|
2025
Q3 | $78.3M | Buy |
161,479
+15,017
| +10% | +$6.99M | 0.32% | 65 |
|
|
2025
Q2 | $59.4M | Buy |
146,462
+10,568
| +8% | +$4.42M | 0.25% | 70 |
|
|
2025
Q1 | $67.6M | Sell |
135,894
-65,125
| -32% | -$35.3M | 0.29% | 60 |
|
|
2024
Q4 | $105M | Sell |
201,019
-55,366
| -22% | -$30.4M | 0.42% | 59 |
|
|
2024
Q3 | $159M | Sell |
256,385
-72,519
| -22% | -$42.9M | 0.57% | 48 |
|
|
2024
Q2 | $182M | Buy |
328,904
+18,107
| +6% | +$10.4M | 0.72% | 36 |
|
|
2024
Q1 | $181M | Sell |
310,797
-285,597
| -48% | -$160M | 0.64% | 41 |
|
|
2023
Q4 | $317M | Sell |
596,394
-47,359
| -7% | -$22.9M | 1.13% | 31 |
|
|
2023
Q3 | $326M | Buy |
643,753
+140,220
| +28% | +$74.7M | 1.34% | 23 |
|
|
2023
Q2 | $263M | Buy |
503,533
+270,661
| +116% | +$146M | 0.98% | 32 |
|
|
2023
Q1 | $134M | Sell |
232,872
-62,243
| -21% | -$35.1M | 0.48% | 51 |
|
|
2022
Q4 | $163M | Buy |
295,115
+20,190
| +7% | +$10.7M | 0.61% | 43 |
|
|
2022
Q3 | $139M | Sell |
274,925
-34,489
| -11% | -$19.3M | 0.49% | 48 |
|
|
2022
Q2 | $168M | Sell |
309,414
-3,894
| -1% | -$2.14M | 0.54% | 49 |
|
|
2022
Q1 | $185M | Sell |
313,308
-8,214
| -3% | -$4.72M | 0.6% | 46 |
|
|
2021
Q4 | $215M | Sell |
321,522
-147,596
| -31% | -$92.2M | 0.58% | 50 |
|
|
2021
Q3 | $268M | Sell |
469,118
-107,134
| -19% | -$58.8M | 0.9% | 36 |
|
|
2021
Q2 | $291M | Buy |
576,252
+17,897
| +3% | +$8.44M | 0.99% | 33 |
|
|
2021
Q1 | $255M | Buy |
558,355
+11,329
| +2% | +$5.41M | 0.93% | 32 |
|
|
2020
Q4 | $255M | Buy |
547,026
+183,871
| +51% | +$86.2M | 1.05% | 29 |
|
|
2020
Q3 | $160M | Sell |
363,155
-37,575
| -9% | -$15.5M | 0.79% | 37 |
|
|
2020
Q2 | $145M | Sell |
400,730
-18,781
| -4% | -$6.3M | 0.83% | 34 |
|
|
2020
Q1 | $119M | Sell |
419,511
-58,453
| -12% | -$18.4M | 0.82% | 37 |
|
|
2019
Q4 | $155M | Buy |
477,964
+3,232
| +0.7% | +$980K | 0.98% | 36 |
|
|
2019
Q3 | $138M | Buy |
474,732
+51,181
| +12% | +$14.7M | 0.94% | 37 |
|
|
2019
Q2 | $124M | Sell |
423,551
-127,338
| -23% | -$35.1M | 0.85% | 39 |
|
|
2019
Q1 | $151M | Sell |
550,889
-512,044
| -48% | -$127M | 1.02% | 35 |
|
|
2018
Q4 | $238M | Sell |
1,062,933
-74,263
| -7% | -$17.4M | 1.8% | 24 |
|
|
2018
Q3 | $278M | Sell |
1,137,196
-7,636
| -0.7% | -$1.76M | 2.05% | 15 |
|
|
2018
Q2 | $237M | Buy |
1,144,832
+24,907
| +2% | +$5.29M | 1.91% | 22 |
|
|
2018
Q1 | $231M | Buy |
1,119,925
+47,767
| +4% | +$10M | 1.89% | 21 |
|
|
2017
Q4 | $204M | Sell |
1,072,158
-74,199
| -6% | -$14.2M | 1.62% | 25 |
|
|
2017
Q3 | $217M | Sell |
1,146,357
-26,561
| -2% | -$4.81M | 1.65% | 23 |
|
|
2017
Q2 | $205M | Sell |
1,172,918
-1,531,615
| -57% | -$257M | 1.46% | 25 |
|
|
2017
Q1 | $415M | Buy |
2,704,533
+125,262
| +5% | +$19.1M | 3.1% | 9 |
|
|
2016
Q4 | $364M | Buy |
2,579,271
+295,545
| +13% | +$43.6M | 2.98% | 6 |
|
|
2016
Q3 | $363M | Sell |
2,283,726
-70,231
| -3% | -$10.8M | 3.14% | 7 |
|
|
2016
Q2 | $348M | Sell |
2,353,957
-444,208
| -16% | -$65.6M | 3.06% | 7 |
|
|
2016
Q1 | $396M | Buy |
2,798,165
+1,428,822
| +104% | +$191M | 3.32% | 5 |
|
|
2015
Q4 | $194M | Sell |
1,369,343
-167,836
| -11% | -$22.4M | 1.86% | 19 |
|
|
2015
Q3 | $188M | Buy |
1,537,179
+241,095
| +19% | +$31.4M | 1.79% | 21 |
|
|
2015
Q2 | $168M | Buy |
1,296,084
+442,163
| +52% | +$57.6M | 1.53% | 25 |
|
|
2015
Q1 | $115M | Sell |
853,921
-49,990
| -6% | -$6.44M | 1.04% | 34 |
|
|
2014
Q4 | $113M | Buy |
903,911
+308,180
| +52% | +$37.5M | 1.06% | 33 |
|
|
2014
Q3 | $72.5M | Buy |
595,731
+24,344
| +4% | +$2.96M | 0.75% | 44 |
|
|
2014
Q2 | $67.4M | Buy |
571,387
+36,778
| +7% | +$4.33M | 0.69% | 46 |
|
|
2014
Q1 | $64.3M | Buy |
534,609
+28,570
| +6% | +$3.4M | 0.7% | 44 |
|
|
2013
Q4 | $56.3M | Buy |
506,039
+218,750
| +76% | +$21.8M | 0.59% | 46 |
|
|
2013
Q3 | $26.5M | Sell |
287,289
-39,802
| -12% | -$3.6M | 0.36% | 59 |
|
|
2013
Q2 | $27.7M | Buy |
+327,091
| New | +$27.2M | 0.39% | 52 |
|
Other funds holding TMO
VCM
Select Equity Group's TMO Position: Q1 2026 in Review
Select Equity Group reduced its Thermo Fisher Scientific (TMO) stake by 4.9% in Q1 2026, selling an estimated $8.43M and leaving 299,500 shares worth $147M. The position accounts for 0.75% of the portfolio, ranked #38.
Select Equity Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $415M in Q1 2017. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Select Equity Group held 299,500 shares of Thermo Fisher Scientific worth $147M as of Q1 2026.
- Select Equity Group sold 15,532 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.43M.
- Thermo Fisher Scientific made up 0.75% of Select Equity Group's portfolio in Q1 2026, its #38 holding.
- Select Equity Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Select Equity Group's Thermo Fisher Scientific position peaked at $415M in Q1 2017.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Select Equity Group's 13F filing for Q1 2026, filed 15 May 2026.